Literature DB >> 18172326

Circulating levels of inflammatory cytokines and risk of colorectal adenomas.

Sangmi Kim1, Temitope O Keku, Christopher Martin, Joseph Galanko, John T Woosley, Jane C Schroeder, Jessie A Satia, Susan Halabi, Robert S Sandler.   

Abstract

The association between obesity and colorectal neoplasia may be mediated by inflammation. Circulating levels of C-reactive protein (CRP), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-alpha) are elevated in the obese. Adipose tissue can produce and release the inflammatory cytokines that are potentially procarcinogenic. We examined circulating levels of CRP, IL-6, and TNF-alpha in relation to risk factors and the prevalence of colorectal adenomas. Plasma levels of CRP, IL-6, and TNF-alpha were quantified in 873 participants (242 colorectal adenoma cases and 631 controls) in a colonoscopy-based cross-sectional study conducted between 1998 and 2002. Multivariable logistic regression was used to estimate associations between known risk factors for colorectal neoplasia and circulating levels of inflammatory cytokines and associations between inflammatory cytokines and colorectal adenomas. Several known risk factors for colorectal neoplasia were associated with higher levels of inflammatory cytokines, including older age, current smoking, and increasing adiposity. The prevalence of colorectal adenomas was associated with higher concentrations of IL-6 and TNF-alpha and, to a lesser degree, with CRP. For IL-6, adjusted odds ratios (OR) for colorectal adenomas were 1.79 [95% confidence interval (CI), 1.19-2.69] for the second highest plasma level and 1.85 (95% CI, 1.24-2.75) for the highest level compared with the reference level. A similar association was found with TNF-alpha, with adjusted ORs of 1.56 (95% CI, 1.03-2.36) and 1.66 (95% CI, 1.10-2.52), respectively. Our findings indicate that systemic inflammation might be involved in the early development of colorectal neoplasia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18172326      PMCID: PMC2675825          DOI: 10.1158/0008-5472.CAN-07-2924

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  39 in total

Review 1.  Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty.

Authors:  W B Ershler; E T Keller
Journal:  Annu Rev Med       Date:  2000       Impact factor: 13.739

Review 2.  Cytokine-related aging process.

Authors:  John E Morley; Richard N Baumgartner
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2004-09       Impact factor: 6.053

Review 3.  Paradoxical roles of the immune system during cancer development.

Authors:  Karin E de Visser; Alexandra Eichten; Lisa M Coussens
Journal:  Nat Rev Cancer       Date:  2006-01       Impact factor: 60.716

Review 4.  The effect of weight loss on a stable biomarker of inflammation, C-reactive protein.

Authors:  Marion Dietrich; Ishwarlal Jialal
Journal:  Nutr Rev       Date:  2005-01       Impact factor: 7.110

5.  Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial.

Authors:  Katherine Esposito; Alessandro Pontillo; Carmen Di Palo; Giovanni Giugliano; Mariangela Masella; Raffaele Marfella; Dario Giugliano
Journal:  JAMA       Date:  2003-04-09       Impact factor: 56.272

6.  Effects of low-dose aspirin on serum C-reactive protein and thromboxane B2 concentrations: a placebo-controlled study using a highly sensitive C-reactive protein assay.

Authors:  M Feldman; I Jialal; S Devaraj; B Cryer
Journal:  J Am Coll Cardiol       Date:  2001-06-15       Impact factor: 24.094

7.  Inflammation-related gene polymorphisms and colorectal adenoma.

Authors:  Marc J Gunter; Federico Canzian; Stefano Landi; Stephen J Chanock; Rashmi Sinha; Nathaniel Rothman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-06       Impact factor: 4.254

8.  Interrelationships among circulating interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women.

Authors:  Edmund A Bermudez; Nader Rifai; Julie Buring; JoAnn E Manson; Paul M Ridker
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-10-01       Impact factor: 8.311

9.  Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects.

Authors:  R P Tracy; B M Psaty; E Macy; E G Bovill; M Cushman; E S Cornell; L H Kuller
Journal:  Arterioscler Thromb Vasc Biol       Date:  1997-10       Impact factor: 8.311

10.  A prospective study of serum C-reactive protein and colorectal cancer risk in men.

Authors:  Marc J Gunter; Rachael Stolzenberg-Solomon; Amanda J Cross; Michael F Leitzmann; Stephanie Weinstein; Richard J Wood; Jarmo Virtamo; Philip R Taylor; Demetrius Albanes; Rashmi Sinha
Journal:  Cancer Res       Date:  2006-02-15       Impact factor: 12.701

View more
  119 in total

1.  Comparison of tumor and microenvironment secretomes in plasma and in platelets during prostate cancer growth in a xenograft model.

Authors:  Bethany A Kerr; Ranko Miocinovic; Armine K Smith; Eric A Klein; Tatiana V Byzova
Journal:  Neoplasia       Date:  2010-05       Impact factor: 5.715

Review 2.  IL6 gene polymorphisms and susceptibility to colorectal cancer: a meta-analysis and review.

Authors:  Yong Yu; Wenjun Wang; Song Zhai; Shuangsuo Dang; Mingzhu Sun
Journal:  Mol Biol Rep       Date:  2012-06-20       Impact factor: 2.316

3.  Obesity-related parameters and colorectal adenoma development.

Authors:  Tae Jun Kim; Jee Eun Kim; Yoon-Ho Choi; Sung Noh Hong; Young-Ho Kim; Dong Kyung Chang; Poong-Lyul Rhee; Min-Ji Kim; Sin-Ho Jung; Hee Jung Son
Journal:  J Gastroenterol       Date:  2017-02-14       Impact factor: 7.527

4.  C-reactive protein and risk of colorectal adenoma according to celecoxib treatment.

Authors:  Andrew T Chan; Camelia S Sima; Ann G Zauber; Paul M Ridker; Ernest T Hawk; Monica M Bertagnolli
Journal:  Cancer Prev Res (Phila)       Date:  2011-08

5.  Factors associated with inflammation markers, a cross-sectional analysis.

Authors:  Tess V Clendenen; Karen L Koenig; Alan A Arslan; Annekatrin Lukanova; Franco Berrino; Yian Gu; Goran Hallmans; Annika Idahl; Vittorio Krogh; Anna E Lokshin; Eva Lundin; Paola Muti; Adele Marrangoni; Brian M Nolen; Nina Ohlson; Roy E Shore; Sabina Sieri; Anne Zeleniuch-Jacquotte
Journal:  Cytokine       Date:  2011-10-19       Impact factor: 3.861

6.  Risk of Colorectal Neoplasia According to Fatty Liver Severity and Presence of Gall Bladder Polyps.

Authors:  Taeyoung Lee; Kyung Eun Yun; Yoosoo Chang; Seungho Ryu; Dong Il Park; Kyuyong Choi; Yoon Suk Jung
Journal:  Dig Dis Sci       Date:  2015-09-18       Impact factor: 3.199

Review 7.  The association between metabolic syndrome and colorectal neoplasm: systemic review and meta-analysis.

Authors:  Raxitkumar Jinjuvadia; Prateek Lohia; Chetna Jinjuvadia; Sergio Montoya; Suthat Liangpunsakul
Journal:  J Clin Gastroenterol       Date:  2013-01       Impact factor: 3.062

Review 8.  Tumor necrosis factor and cancer, buddies or foes?

Authors:  Xia Wang; Yong Lin
Journal:  Acta Pharmacol Sin       Date:  2008-11       Impact factor: 6.150

Review 9.  How ageing processes influence cancer.

Authors:  João Pedro de Magalhães
Journal:  Nat Rev Cancer       Date:  2013-05       Impact factor: 60.716

10.  Central obesity and atherogenic dyslipidemia in metabolic syndrome are associated with increased risk for colorectal adenoma in a Chinese population.

Authors:  Chiu-Shong Liu; Hua-Shui Hsu; Chia-Ing Li; Chia-Ing Jan; Tsai-Chung Li; Wen-Yuan Lin; Tsann Lin; Ya-Chien Chen; Cheng-Chun Lee; Cheng-Chieh Lin
Journal:  BMC Gastroenterol       Date:  2010-05-27       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.